Stephanie Nolen
Posts
In Southern Africa, Success Against H.I.V. Offers Hope for Beating Back Another Virus
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus...
In Southern Africa, Success Against H.I.V. Offers Hope for Beating Back Another Virus
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus...
Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron
They do seem to offer significant protection against severe illness, but the consequences of rapidly spreading infection worry many public health experts.
How Conflicting Guidance on Travel During the Pandemic Shows Little Progress
The Omicron variant turned my trip home from South Africa into a nightmare episode of conflicting public health orders that often seemed to have little...
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen...
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen...
Merck Will Share Formula for its Covid Pill With Poor Countries
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.
Gates Foundation Pledges $120 Million to Help Get Covid Pills Quickly to Poor Countries
Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.
Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
An Experimental H.I.V. Vaccine Fails in Africa
Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.